Skip to content

A study on Ayurvedic treatment for abnormal Blood Lipid levels.

A Clinical Study On Ayurvedic Management Of Dyslipidaemia. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/01/100535
Enrollment
30
Registered
2026-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

J.S Ayurveda Mahavidhyalaya and P.D Patel Ayurved Hospital,Nadiad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis will be made on the basis of (NCEP) Adult Treatment Panel 3. Following range of values will be taken for diagnosis of Dyslipidaemia. Serum cholesterol higher than 200 mg/dl or/and Serum triglyceride higher than 150 mg/dl or/and Serum LDL than 130 mg/dl or/and Serum VLDL than 40 mg/dl or/and Serum HDL than 40 mg/dl The change in any one or more of the above parameters of lipid profile i.e. increase in Serum cholesterol, Serum triglyceride, S.LDL, S. VLDL or decrease in S. HDL will be considered for diagnosis of Dyslipidaemia. Patients fulfilling diagnostic criteria. Patients who are suitable for Shodhanartha Snehapana, Virechana karma, Lekhana Basti and Udvartana. Patients currently receiving Anti platelet therapy will be included in the study, and these medications will be continued throughout the study period.

Exclusion criteria

Exclusion criteria: Patients who are not suitable for Shodhanartha Snehapana, Virechana karma, Lekhana Basti and Udvartana. Age below 18 years and more than 60 years Pregnant or Lactating women. Patients with severe systemic illness like uncontrolled Hypertension, uncontrolled Diabetes Mellitus, Nephrotic Syndrome, Chronic Liver Disease, Chronic Kidney Disease, Tuberculosis, etc.

Design outcomes

Primary

MeasureTime frame
To evaluate the changes in Lipid Profile before and after treatment.Timepoint: Total 2 months 1 month I.P.D treatment and 1 month O.P.D treatment.

Secondary

MeasureTime frame
To observe the changes in Body Mass Index before and after treatment.Timepoint: Total 2 months 1 month I.P.D treatment and 1 month O.P.D treatment.

Countries

India

Contacts

Public ContactProf Dr Jaimin R Patel
vd.jaimin@gmail.com9427859535

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026